Cargando…
Doxorubicin and Aclarubicin: Shuffling Anthracycline Glycans for Improved Anticancer Agents
[Image: see text] Anthracycline anticancer drugs doxorubicin and aclarubicin have been used in the clinic for several decades to treat various cancers. Although closely related structures, their molecular mode of action diverges, which is reflected in their biological activity profile. For a better...
Autores principales: | Wander, Dennis P. A., van der Zanden, Sabina Y., van der Marel, Gijsbert A., Overkleeft, Herman S., Neefjes, Jacques, Codée, Jeroen D. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667640/ https://www.ncbi.nlm.nih.gov/pubmed/33064004 http://dx.doi.org/10.1021/acs.jmedchem.0c01191 |
Ejemplares similares
-
Synthetic (N,N-Dimethyl)doxorubicin
Glycosyl Diastereomers to Dissect Modes of Action of Anthracycline
Anticancer Drugs
por: Wander, Dennis P. A., et al.
Publicado: (2021) -
Re-Exploring
the Anthracycline Chemical Space for
Better Anti-Cancer Compounds
por: van Gelder, Merle A., et al.
Publicado: (2023) -
The identification of the anthracycline aclarubicin as an effective cytotoxic agent for pancreatic cancer
por: Brouwer, Thomas P., et al.
Publicado: (2022) -
New insights into the activities and toxicities of the old anticancer drug doxorubicin
por: van der Zanden, Sabina Y., et al.
Publicado: (2020) -
Reagent
Controlled Stereoselective Synthesis of α-Glucans
por: Wang, Liming, et al.
Publicado: (2018)